Decentralized Manufacturing

Implementing the 7Talos platform through a decentralized approach in multiple hospitals that provide CAR-T cell treatments offers a range of substantial advantages:

Quicker Treatment Delivery

Localizing the platform in hospitals significantly reduces the time between production and administration of CAR-T cell therapies, which is crucial for time-sensitive treatment

Cost
Reduction

By cutting down on transportation and logistics expenses, decentralization can make these advanced therapies more affordable for both healthcare systems and patients.

Increased Accessibility

Decentralizing the platform improves access to advanced CAR-T cell therapies for a larger number of patients by reducing the need for them to travel long distances.

Enhanced Quality and Safety

Localized production enables closer monitoring and control over the manufacturing process, reducing the risk of contamination and boosting therapy quality and safety.

Personalized Care

Proximity to patients allows for more immediate and tailored adjustments to therapies, leading to more effective and individualized treatment regimens.